Key points are not available for this paper at this time.
Drug-coated balloons (DCBs) may be a viable alternative to drug-eluting stents (DES) for de novo small caliber coronary artery lesions. However, there remains a lack of data regarding the long-term efficacy of this approach.
Angheluta et al. (Mon,) studied this question.